Tudor Investment Corp’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.4M | Sell |
84,550
-41,543
| -33% | -$21.8M | 0.1% | 38 |
|
|
2025
Q1 | $80M | Buy |
126,093
+97,523
| +341% | +$61.9M | 0.27% | 14 |
|
|
2024
Q4 | $20.4M | Sell |
28,570
-9,081
| -24% | -$6.47M | 0.08% | 96 |
|
|
2024
Q3 | $39.6M | Buy |
+37,651
| New | +$39.6M | 0.14% | 26 |
|
|
2023
Q4 | – | Sell |
-5,799
| Closed | -$4.77M | – | 1870 |
|
|
2023
Q3 | $4.77M | Sell |
5,799
-7,847
| -58% | -$6.46M | 0.05% | 369 |
|
|
2023
Q2 | $9.81M | Buy |
13,646
+10,574
| +344% | +$7.6M | 0.12% | 150 |
|
|
2023
Q1 | $2.52M | Sell |
3,072
-542
| -15% | -$445K | 0.04% | 562 |
|
|
2022
Q4 | $2.61M | Buy |
+3,614
| New | +$2.61M | 0.05% | 431 |
|
|
2022
Q3 | – | Sell |
-1,690
| Closed | -$999K | – | 1913 |
|
|
2022
Q2 | $999K | Buy |
+1,690
| New | +$999K | 0.03% | 808 |
|
|
2021
Q3 | – | Sell |
-1,591
| Closed | -$889K | – | 1895 |
|
|
2021
Q2 | $889K | Buy |
+1,591
| New | +$889K | 0.02% | 871 |
|
|
2020
Q2 | – | Sell |
-2,426
| Closed | -$1.19M | – | 1369 |
|
|
2020
Q1 | $1.19M | Sell |
2,426
-2,670
| -52% | -$1.3M | 0.11% | 199 |
|
|
2019
Q4 | $1.91M | Buy |
+5,096
| New | +$1.91M | 0.09% | 295 |
|
|
2019
Q3 | – | Sell |
-785
| Closed | -$246K | – | 1285 |
|
|
2019
Q2 | $246K | Sell |
785
-1,650
| -68% | -$517K | 0.01% | 904 |
|
|
2019
Q1 | $1M | Buy |
+2,435
| New | +$1M | 0.04% | 463 |
|
|
2018
Q4 | – | Sell |
-1,278
| Closed | -$516K | – | 1186 |
|
|
2018
Q3 | $516K | Sell |
1,278
-7,754
| -86% | -$3.13M | 0.01% | 664 |
|
|
2018
Q2 | $3.12M | Buy |
+9,032
| New | +$3.12M | 0.11% | 145 |
|
|
2018
Q1 | – | Sell |
-4,017
| Closed | -$1.51M | – | 1179 |
|
|
2017
Q4 | $1.51M | Buy |
+4,017
| New | +$1.51M | 0.04% | 234 |
|
|
2017
Q2 | – | Sell |
-600
| Closed | -$233K | – | 1306 |
|
|
2017
Q1 | $233K | Buy |
+600
| New | +$233K | 0.01% | 1146 |
|
|
2016
Q4 | – | Sell |
-4,608
| Closed | -$1.85M | – | 1547 |
|
|
2016
Q3 | $1.85M | Buy |
4,608
+1,652
| +56% | +$664K | 0.04% | 216 |
|
|
2016
Q2 | $1.03M | Buy |
+2,956
| New | +$1.03M | 0.02% | 351 |
|
|
2016
Q1 | – | Sell |
-700
| Closed | -$380K | – | 1676 |
|
|
2015
Q4 | $380K | Sell |
700
-390
| -36% | -$212K | 0.01% | 953 |
|
|
2015
Q3 | $507K | Buy |
1,090
+690
| +173% | +$321K | 0.02% | 723 |
|
|
2015
Q2 | $204K | Buy |
+400
| New | +$204K | 0.01% | 1290 |
|
|
2014
Q4 | – | Sell |
-2,499
| Closed | -$901K | – | 1558 |
|
|
2014
Q3 | $901K | Buy |
+2,499
| New | +$901K | 0.03% | 331 |
|
|
2014
Q2 | – | Sell |
-893
| Closed | -$268K | – | 1271 |
|
|
2014
Q1 | $268K | Buy |
+893
| New | +$268K | 0.01% | 865 |
|
|
2013
Q3 | – | Sell |
-1,600
| Closed | -$360K | – | 919 |
|
|
2013
Q2 | $360K | Buy |
+1,600
| New | +$360K | 0.03% | 461 |
|